Pathological classification and molecular genetics of meningiomas

Journal of Neuro-Oncology

Volumn 99, Issue 3, 2010, Pages 379-391

  Mawrin, Christian ^b   Perry, Arie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Meningioma; Molecular genetics; Pathology

Indexed keywords

BETA CATENIN; BREAKPOINT CLUSTER REGION PROTEIN; CARCINOEMBRYONIC ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; KI 67 ANTIGEN; NEUROFIBROMIN; ONCOPROTEIN; OSTEOPONTIN; PROGESTERONE RECEPTOR; PROTEIN BAM22; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

CANCER CLASSIFICATION; CANCER GRADING; CARCINOGENESIS; CEREBROSPINAL FLUID ANALYSIS; CHROMOSOME LOSS; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MELANOMA; MENINGIOMA; MOLECULAR GENETICS; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MOLECULAR BIOLOGY;

EID: 77957567036     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0342-2     Document Type: Review

References (93)

1. Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 1997-2001. In: CBTRUS (ed). Hinsdale, IL
2. S Nakasu A Hirano T Shimura JF Llena 1987 Incidental meningiomas in autopsy study Surg Neurol 27 319 322 1:STN:280:DyaL2s7kvFGgsg%3D%3D 10.1016/0090-3019(87)90005-X 3824137 (Pubitemid 17049781)
3. MW Vernooij MA Ikram HL Tanghe AJ Vincent A Hofman GP Krestin WJ Niessen MM Breteler A van der Lugt 2007 Incidental findings on brain MRI in the general population N Engl J Med 357 1821 1828 1:CAS:528:DC%2BD2sXht1Kit7fO 10.1056/NEJMoa070972 17978290 (Pubitemid 350044802)
4. A Perry EA Lusis DH Gutmann 2005 Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases Brain Pathol 15 109 115 10.1111/j.1750-3639.2005.tb00505.x 15912882
5. B Borovich Y Doron 1986 Recurrence of intracranial meningiomas: the role played by regional multicentricity J Neurosurg 64 58 63 1:STN:280: DyaL28%2FovVWgsQ%3D%3D 10.3171/jns.1986.64.1.0058 3941351
6. AP Stangl R Wellenreuther D Lenartz JA Kraus AG Menon J Schramm OD Wiestler A von Deimling 1997 Clonality of multiple meningiomas J Neurosurg 86 853 858 1:STN:280:DyaK2s3nt1SmtQ%3D%3D 10.3171/jns.1997.86.5.0853 9126902
7. A Perry SL Stafford BW Scheithauer VJ Suman CM Lohse 1997 Meningioma grading: an analysis of histologic parameters Am J Surg Pathol 21 1455 1465 1:STN:280:DyaK1c%2FnsFSjsg%3D%3D 10.1097/00000478-199712000-00008 9414189 (Pubitemid 27528256)
8. A Durand F Labrousse A Jouvet L Bauchet M Kalamarides P Menei R Deruty JJ Moreau M Fevre-Montange J Guyotat 2009 WHO grade II and III meningiomas: a study of prognostic factors J Neurooncol 95 367 375 10.1007/s11060-009-9934-0 19562258
9. A Perry BW Scheithauer SL Stafford CM Lohse PC Wollan 1999 "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications Cancer 85 2046 2056 1:STN:280: DyaK1M3jslOmug%3D%3D 10223247
10. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG II (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56-60; discussion 60
11. Louis DN, Scheithauer BW, Budka H, Von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC press, Lyon, pp 176-184
12. Smith SJ, Boddu S, Macarthur DC (2007) Atypical meningiomas: WHO moved the goalposts? Br J Neurosurg 21:588-592
13. Perry A, Louis DN, Scheithauer BW, Budka H, Von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 164-172
14. S Hirota Y Nakajima T Yoshimine K Kohri S Nomura M Taneda T Hayakawa Y Kitamura 1995 Expression of bone-related protein messenger RNA in human meningiomas: possible involvement of osteopontin in development of psammoma bodies J Neuropathol Exp Neurol 54 698 703 1:CAS:528:DyaK2MXoslSmtLg%3D 10.1097/00005072-199509000-00012 7666059
15. DN Louis AJ Hamilton RA Sobel RG Ojemann 1991 Pseudopsammomatous meningioma with elevated serum carcinoembryonic antigen: a true secretory meningioma. Case report J Neurosurg 74 129 132 1:STN:280:DyaK3M%2FnvFyqsQ%3D%3D 10.3171/jns.1991.74.1.0129 1984492
16. JJ Kepes WY Chen MH Connors FS Vogel 1988 "Chordoid" meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases Cancer 62 391 406 1:STN:280:DyaL1c3ltlWnuw%3D%3D 10.1002/1097- 0142(19880715)62:2<391::AID-CNCR2820620226>3.0.CO;2-7 3383139
17. J-W Lin J-T Ho Y-J Lin Y-T Wu 2010 Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution J Neurooncol 10.1007/s11060-010-0211-z
18. ME Couce FV Aker BW Scheithauer 2000 Chordoid meningioma: a clinicopathologic study of 42 cases Am J Surg Pathol 24 899 905 1:STN:280:DC%2BD3czlt1KqtA%3D%3D 10.1097/00000478-200007000-00001 10895812 (Pubitemid 30430477)
19. ML Tena-Suck MA Collado-Ortiz C Salinas-Lara R Garcia-Lopez N Gelista D Rembao-Bojorquez 2010 Chordoid meningioma: a report of ten cases J Neurooncol 99 1 41 48 10.1007/s11060-009-0097-9 20094774
20. A Perry BW Scheithauer SL Stafford PC Abell-Aleff FB Meyer 1998 "Rhabdoid" meningioma: an aggressive variant Am J Surg Pathol 22 1482 1490 1:STN:280:DyaK1M%2FmsFChtA%3D%3D 10.1097/00000478-199812000-00005 9850174 (Pubitemid 28550643)
21. C Mawrin R Hahne C Scherlach E Kirches K Dietzmann 2004 June 2004: a male in his late 60s with recurrent extracerebral tumor Brain Pathol 14 457 459 10.1111/j.1750-3639.2004.tb00092.x 15605995
22. SM Grunberg MH Weiss CA Russell IM Spitz J Ahmadi A Sadun R Sitruk-Ware 2006 Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma Cancer Invest 24 727 733 1:CAS:528: DC%2BD2sXhs1WntLc%3D 10.1080/07357900601062339 17162554 (Pubitemid 44949876)
23. A Perry SL Stafford BW Scheithauer VJ Suman CM Lohse 1998 The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas Cancer 82 2262 2269 1:STN:280:DyaK1c3nt1aguw%3D%3D 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R 9610708 (Pubitemid 28240835)
24. S Nakasu DH Li H Okabe M Nakajima M Matsuda 2001 Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods Am J Surg Pathol 25 472 478 1:STN:280:DC%2BD3M3hslSjsA%3D%3D 10.1097/00000478-200104000- 00006 11257621 (Pubitemid 32240886)
25. E Karamitopoulou E Perentes M Tolnay A Probst 1998 Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas Hum Pathol 29 140 145 1:STN:280:DyaK1c7jvFartw%3D%3D 10.1016/S0046-8177(98)90224-6 9490273 (Pubitemid 28099509)
26. S Nakasu T Fukami J Jito K Nozaki 2009 Recurrence and regrowth of benign meningiomas Brain Tumor Pathol 26 69 72 10.1007/s10014-009-0251-2 19856217
27. K Nakaya M Chernov H Kasuya M Izawa M Hayashi K Kato O Kubo Y Muragaki H Iseki T Hori Y Okada K Takakura 2009 Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index Minim Invasive Neurosurg 52 216 221 1:STN:280: DC%2BC3c%2FislymsA%3D%3D 10.1055/s-0029-1243244 20077361
28. V Karja PJ Sandell T Kauppinen I Alafuzoff 2010 Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Hum Pathol 41 199 207 10.1016/j.humpath.2009.06.020 19801161
29. SH Torp CF Lindboe US Granli TM Moen T Nordtomme 2001 Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas Clin Neuropathol 20 190 195 1:STN:280:DC%2BD3MrkvVShuw%3D%3D 11594503
30. T Ribalta IE McCutcheon KD Aldape JM Bruner GN Fuller 2004 The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria Am J Surg Pathol 28 1532 1536 10.1097/01.pas.0000141389.06925.d5 15489659 (Pubitemid 39425522)
31. S Fukushima M Terasaki K Sakata N Miyagi S Kato Y Sugita M Shigemori 2009 Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases Brain Tumor Pathol 26 51 57 10.1007/s10014-009-0249-9 19856215
32. A Perry MR Chicoine E Filiput JP Miller DT Cross 2001 Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients Cancer 92 701 711 1:STN:280:DC%2BD3Mvmtl2nsw%3D%3D 10.1002/1097- 0142(20010801)92:3<701::AID-CNCR1373>3.0.CO;2-7 11505418 (Pubitemid 32735209)
33. H Ohgaki P Kleihues 2009 Genetic alterations and signaling pathways in the evolution of gliomas Cancer Sci 100 2235 2241 1:CAS:528:DC%2BD1MXhsFOltrvN 10.1111/j.1349-7006.2009.01308.x 19737147
34. J Jaaskelainen 1986 Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis Surg Neurol 26 461 469 1:STN:280:DyaL2s%2FhvFemtg%3D%3D 10.1016/0090-3019(86)90259-4 3764651 (Pubitemid 16006137)
35. Kheradmand A, Smith T: Dural metastatic adenocarcinoma mimicking meningioma. Neurology 74:1396
36. Richiello A, Sparano L, Del Basso De Caro ML, Russo G (2003) Dural metastasis mimicking falx meningioma. Case report. J Neurosurg Sci 47:167-171; discussion 171
37. A Ambrosini-Spaltro V Eusebi 2010 Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison Virchows Arch 456 343 354 10.1007/s00428-010-0888-6 20165866
38. A Mekni J Kourda KB Hammouda M Tangour N Kchir M Zitouna S Haouet 2009 Solitary fibrous tumour of the central nervous system: pathological study of eight cases and review of the literature Pathology 41 649 654 10.3109/00313020903071439 19672786
39. T Psaras G Pantazis V Steger R Meyermann J Honegger R Beschorner 2009 Benign meningioma developing late lung metastases: case report and review of the literature Clin Neuropathol 28 453 459 1:STN:280:DC%2BD1MjmslynsQ%3D%3D 19919820
40. EM Azene QW Gai SP Tabar AL Morrison B Meisenberg 2008 Metastasis of a histologically benign-appearing meningioma to the iliac bone J Clin Oncol 26 4688 4690 10.1200/JCO.2008.17.7337 18824717
41. A Mahore A Chagla A Goel 2010 Seeding metastases of a benign intraventricular meningioma along the surgical track J Clin Neurosci 17 253 255 10.1016/j.jocn.2009.05.025 20036547
42. S Albrecht JC Goodman S Rajagopolan M Levy DA Cech LD Cooley 1994 Malignant meningioma in Gorlin's syndrome: cytogenetic and p53 gene analysis. Case report J Neurosurg 81 466 471 1:STN:280:DyaK2czjsVOgtQ%3D%3D 10.3171/jns.1994.81.3.0466 8057157
43. CF Lindboe E Helseth G Myhr 1995 Lhermitte-Duclos disease and giant meningioma as manifestations of Cowden's disease Clin Neuropathol 14 327 330 1:STN:280:DyaK287mslGjug%3D%3D 8605738
44. J De Moura FL Kavalec M Doghman R Rosati G Custodio E Lalli GM Cavallari J Santa Maria BC Figueiredo 2010 Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage Int J Oncol 36 983 990 20198344
45. F Marini A Falchetti F Del Monte S Carbonell Sala A Gozzini E Luzi ML Brandi 2006 Multiple endocrine neoplasia type 1 Orphanet J Rare Dis 1 38 10.1186/1750-1172-1-38 17014705
46. MH Ruttledge J Sarrazin S Rangaratnam CM Phelan E Twist P Merel O Delattre G Thomas M Nordenskjold VP Collins, et al. 1994 Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas Nat Genet 6 180 184 1:CAS:528:DyaK2cXhs1SgtrY%3D 10.1038/ng0294-180 8162072 (Pubitemid 24188600)
47. J Lomas MJ Bello D Arjona ME Alonso V Martinez-Glez I Lopez-Marin C Aminoso JM de Campos A Isla J Vaquero JA Rey 2005 Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas Genes Chromosomes Cancer 42 314 319 1:CAS:528:DC%2BD2MXht1Cnsb4%3D 10.1002/gcc.20141 15609345 (Pubitemid 40171195)
48. Y Kimura H Koga N Araki N Mugita N Fujita H Takeshima T Nishi T Yamashima TC Saido T Yamasaki K Moritake H Saya M Nakao 1998 The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas Nat Med 4 915 922 1:CAS:528:DyaK1cXltVCjtLs%3D 10.1038/nm0898-915 9701243 (Pubitemid 28364030)
49. CM Hansson PG Buckley G Grigelioniene A Piotrowski AR Hellstrom K Mantripragada C Jarbo T Mathiesen JP Dumanski 2007 Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus BMC Genomics 8 16 10.1186/1471-2164-8-16 17222329 (Pubitemid 46210962)
50. R Wellenreuther JA Kraus D Lenartz AG Menon J Schramm DN Louis V Ramesh JF Gusella OD Wiestler A von Deimling 1995 Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma Am J Pathol 146 827 832 1:STN:280:DyaK2M3jtlCqsw%3D%3D 7717450
51. C Hartmann J Sieberns C Gehlhaar M Simon W Paulus A von Deimling 2006 NF2 mutations in secretory and other rare variants of meningiomas Brain Pathol 16 15 19 1:CAS:528:DC%2BD28XpsFeisbs%3D 10.1111/j.1750-3639.2006.tb00557.x 16612978
52. J Kros K de Greve A van Tilborg W Hop H Pieterman C Avezaat R Lekanne Dit Deprez E Zwarthoff 2001 NF2 status of meningiomas is associated with tumour localization and histology J Pathol 194 367 372 1:STN:280:DC%2BD3MzosFenug%3D%3D 10.1002/path.909 11439370 (Pubitemid 32624564)
53. M Peyrard I Fransson YG Xie FY Han MH Ruttledge S Swahn JE Collins I Dunham VP Collins JP Dumanski 1994 Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene Hum Mol Genet 3 1393 1399 1:CAS:528:DyaK2cXmt1egtbw%3D 10.1093/hmg/3.8.1393 7987321
54. K Wozniak S Piaskowski SM Gresner E Golanska E Bieniek K Bigoszewska B Sikorska M Szybka D Kulczycka-Wojdala M Zakrzewska I Zawlik W Papierz R Stawski DJ Jaskolski W Och M Sieruta PP Liberski P Rieske 2008 BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region Cancer Genet Cytogenet 183 14 20 1:CAS:528: DC%2BD1cXlslOrtLc%3D 10.1016/j.cancergencyto.2008.01.020 18474292 (Pubitemid 351637609)
55. D Barski M Wolter G Reifenberger MJ Riemenschneider 2010 Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas Brain Pathol 20 623 631 1:CAS:528:DC%2BC3cXmt1aktrw%3D 10.1111/j.1750-3639.2009.00340.x 19922547
56. DH Gutmann J Donahoe A Perry N Lemke K Gorse K Kittiniyom SA Rempel JA Gutierrez IF Newsham 2000 Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas Hum Mol Genet 9 1495 1500 1:CAS:528:DC%2BD3cXksF2nu7c%3D 10.1093/hmg/9.10.1495 10888600
57. F Nunes Y Shen Y Niida R Beauchamp AO Stemmer-Rachamimov V Ramesh J Gusella M MacCollin 2005 Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma Cancer Genet Cytogenet 162 135 139 1:CAS:528: DC%2BD2MXhtVynt7vI 10.1016/j.cancergencyto.2005.04.003 16213361 (Pubitemid 41423470)
58. C Yi JH McCarty SA Troutman MS Eckman RT Bronson JL Kissil 2005 Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer Mol Cell Biol 25 10052 10059 1:CAS:528:DC%2BD2MXht1altrnO 10.1128/MCB.25.22.10052-10059.2005 16260618 (Pubitemid 41572750)
59. B Heinrich C Hartmann AO Stemmer-Rachamimov DN Louis M MacCollin 2003 Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms Int J Cancer 103 483 488 1:CAS:528:DC%2BD3sXhvVOisw%3D%3D 10.1002/ijc.10840 12478663 (Pubitemid 36020222)
60. VA Robb W Li DH Gutmann 2004 Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression Oncogene 23 3589 3596 1:CAS:528: DC%2BD2cXjsV2ntbY%3D 10.1038/sj.onc.1207445 15116094 (Pubitemid 38658425)
61. Y Liu RF Tian YM Li WP Liu L Cao XL Yang WD Cao X Zhang 2010 The expression of seven 14-3-3 isoforms in human meningioma Brain Res 1336 98 102 1:CAS:528:DC%2BC3cXmtFChurc%3D 10.1016/j.brainres.2010.04.009 20388496
62. EI Surace E Lusis Y Murakami BW Scheithauer A Perry DH Gutmann 2004 Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival J Neuropathol Exp Neurol 63 1015 1027 1:CAS:528:DC%2BD2cXpslCru74%3D 15535129
63. AA van Tilborg B Morolli M Giphart-Gassler A de Vries DA van Geenen I Lurkin JM Kros EC Zwarthoff 2006 Lack of genetic and epigenetic changes in meningiomas without NF2 loss J Pathol 208 564 573 10.1002/path.1909 16353169 (Pubitemid 43329343)
64. LH Carvalho I Smirnov GS Baia Z Modrusan JS Smith P Jun JF Costello MW McDermott SR Vandenberg A Lal 2007 Molecular signatures define two main classes of meningiomas Mol Cancer 6 64 10.1186/1476-4598-6-64 17937814
65. O Al-Mefty PA Kadri S Pravdenkova JR Sawyer C Stangeby M Husain 2004 Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings J Neurosurg 101 210 218 10.3171/jns.2004.101.2.0210 15309910
66. RG Weber J Bostrom M Wolter M Baudis VP Collins G Reifenberger P Lichter 1997 Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression Proc Natl Acad Sci USA 94 14719 14724 1:CAS:528:DyaK1cXis1OltQ%3D%3D 10.1073/pnas.94.26.14719 9405679 (Pubitemid 28041440)
67. D Gabeau-Lacet D Engler S Gupta GA Scangas RA Betensky FG Barker II JS Loeffler DN Louis G Mohapatra 2009 Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome J Neuropathol Exp Neurol 68 1155 1165 1:CAS:528:DC%2BD1MXhtFyntrfL 10.1097/NEN.0b013e3181ba3952 19918127
68. W Krupp H Holland R Koschny M Bauer R Schober H Kirsten M Livrea J Meixensberger P Ahnert 2008 Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics Cancer Genet Cytogenet 184 87 93 1:CAS:528:DC%2BD1cXosVygtbc%3D 10.1016/j.cancergencyto.2008.03.015 18617056 (Pubitemid 351915764)
69. AF Pelz P Klawunde M Skalej P Wieacker E Kirches T Schneider C Mawrin 2007 Novel chromosomal aberrations in a recurrent malignant meningioma Cancer Genet Cytogenet 174 48 53 1:CAS:528:DC%2BD2sXislejsLc%3D 10.1016/j. cancergencyto.2006.10.008 17350466 (Pubitemid 46365974)
70. J Bostrom B Meyer-Puttlitz M Wolter B Blaschke RG Weber P Lichter K Ichimura VP Collins G Reifenberger 2001 Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas Am J Pathol 159 661 669 1:CAS:528:DC%2BD3MXms1Wit7w%3D 11485924
71. A Perry R Banerjee CM Lohse BK Kleinschmidt-DeMasters BW Scheithauer 2002 A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas Brain Pathol 12 183 190 1:CAS:528:DC%2BD38XlvVSjtLg%3D 11958372
72. DX Cai CD James BW Scheithauer FJ Couch A Perry 2001 PS6K amplification characterizes a small subset of anaplastic meningiomas Am J Clin Pathol 115 213 218 1:CAS:528:DC%2BD3MXhtFKgsL4%3D 10.1309/FVNU-7UBY-DXE3-77MT 11211609 (Pubitemid 32150679)
73. EI Surace E Lusis CA Haipek DH Gutmann 2004 Functional significance of S6K overexpression in meningioma progression Ann Neurol 56 295 298 1:CAS:528:DC%2BD2cXnt1enu78%3D 10.1002/ana.20201 15293284 (Pubitemid 39037927)
74. V Martinez-Glez L Alvarez C Franco-Hernandez M Torres-Martin JM de Campos A Isla J Vaquero L Lassaletta JS Castresana C Casartelli JA Rey 2010 Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas Cancer Genet Cytogenet 196 1 6 1:CAS:528:DC%2BD1MXhsFahs73K 10.1016/j.cancergencyto.2009.08.003 19963129
75. X Zhang R Gejman A Mahta Y Zhong KA Rice Y Zhou P Cheunsuchon DN Louis A Klibanski 2010 Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression Cancer Res 70 2350 2358 1:CAS:528:DC%2BC3cXjtFygtLw%3D 10.1158/0008-5472.CAN-09-3885 20179190
76. VJ Amatya Y Takeshima K Inai 2004 Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation Mod Pathol 17 705 710 1:CAS:528:DC%2BD2cXmsVOisb0%3D 10.1038/modpathol.3800111 15073599 (Pubitemid 38715495)
77. T Joachim Z Ram ZH Rappaport M Simon J Schramm OD Wiestler A von Deimling 2001 Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas Int J Cancer 94 218 221 1:CAS:528:DC%2BD3MXntVGksr8%3D 10.1002/ijc.1467 11668501 (Pubitemid 32911416)
78. EA Lusis MA Watson MR Chicoine M Lyman P Roerig G Reifenberger DH Gutmann A Perry 2005 Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma Cancer Res 65 7121 7126 1:CAS:528:DC%2BD2MXns1WrtLc%3D 10.1158/0008-5472.CAN-05- 0043 16103061 (Pubitemid 41161241)
79. Y Liu JC Pang S Dong B Mao WS Poon HK Ng 2005 Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas Hum Pathol 36 416 425 1:CAS:528:DC%2BD2MXjsFGqsLw%3D 10.1016/j.humpath.2005.02. 006 15892004 (Pubitemid 40591813)
80. PG Buckley C Jarbo U Menzel T Mathiesen C Scott SG Gregory CF Langford JP Dumanski 2005 Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci Cancer Res 65 2653 2661 1:CAS:528:DC%2BD2MXjtVeqsL0%3D 10.1158/0008-5472. CAN-04-3651 15805262 (Pubitemid 40490064)
81. J Ruiz A Martinez S Hernandez H Zimman M Ferrer C Fernandez M Saez JA Lopez-Asenjo J Sanz-Ortega 2010 Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II Histol Histopathol 25 341 349 1:CAS:528:DC%2BC3cXislamtL4%3D 20054806
82. S Piaskowski P Rieske M Szybka K Wozniak A Bednarek E Pluciennik D Jaskolski B Sikorska PP Liberski 2005 GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis Cancer Genet Cytogenet 162 63 67 1:CAS:528:DC%2BD2MXhtVWhtLnM 10.1016/j.cancergencyto.2005.02.009 16157202 (Pubitemid 41278472)
83. WK Pfisterer SW Coons F Aboul-Enein WP Hendricks AC Scheck MC Preul 2008 Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue J Neurooncol 87 43 50 10.1007/s11060-007-9498-9 18060363
84. G Wrobel P Roerig F Kokocinski K Neben M Hahn G Reifenberger P Lichter 2005 Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression IntJ Cancer 114 249 256 1:CAS:528:DC%2BD2MXhtFOksrg%3D 10.1002/ijc.20733 (Pubitemid 40194294)
85. N Pecina-Slaus T Nikuseva Martic AJ Deak M Zeljko R Hrascan D Tomas V Musani 2009 Genetic and protein changes of E-cadherin in meningiomas J Cancer Res Clin Oncol 136 695 702 10.1007/s00432-009-0708-z 19908067
86. Zhou K, Wang G, Wang Y, Jin H, Yang S, Liu C (2010) The Potential Involvement of E-cadherin and beta-catenins in Meningioma. PLoS One 5:e11231
87. K Schwechheimer L Zhou W Birchmeier 1998 E-Cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas Virchows Arch 432 163 167 1:CAS:528:DyaK1cXos12jtQ%3D%3D 10.1007/s004280050151 9504862 (Pubitemid 28072609)
88. O Saydam Y Shen T Wurdinger O Senol E Boke MF James BA Tannous AO Stemmer-Rachamimov M Yi RM Stephens C Fraefel JF Gusella AM Krichevsky XO Breakefield 2009 Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway Mol Cell Biol 29 5923 5940 1:CAS:528:DC%2BD1MXhtlKntbjO 10.1128/MCB.00332-09 19703993
89. N Pecina-Slaus T Nikuseva Martic D Tomas V Beros M Zeljko H Cupic 2008 Meningiomas exhibit loss of heterozygosity of the APC gene J Neurooncol 87 63 70 1:CAS:528:DC%2BD1cXivFygtrw%3D 10.1007/s11060-007-9500-6 18066497
90. I Laurendeau M Ferrer D Garrido N D'Haene P Ciavarelli A Basso M Vidaud I Bieche I Salmon I Szijan 2010 Gene expression profiling of the Hedgehog signaling pathway in human meningiomas Mol Med 2010 26
91. J Xie RL Johnson X Zhang JW Bare FM Waldman PH Cogen AG Menon RS Warren LC Chen MP Scott EH Epstein Jr 1997 Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors Cancer Res 57 2369 2372 1:CAS:528:DyaK2sXjvFKit7c%3D 9192811
92. Hankins GR, Sasaki T, Lieu AS, Saulle D, Karimi K, Li JZ, Helm GA (2008) Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Neurosurgery 63:771-780; discussion 780-771
93. Y Lee J Liu S Patel T Cloughesy A Lai H Farooqi D Seligson J Dong L Liau D Becker P Mischel S Shams S Nelson 2010 Genomic landscape of meningiomas Brain Pathol 20 751 762 1:CAS:528:DC%2BC3cXpsVyhtbc%3D 10.1111/j.1750-3639.2009.00356. x 20015288